First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

1. Paz-Ares, L.
2. Ciuleanu, T.-E.
3. Cobo, M.
4. Schenker, M.
5. Zurawski, B.
6. Menezes, J.
7. Richardet, E.
8. Bennouna, J.
9. Felip, E.
10. Juan-Vidal, O.
11. Alexandru, A.
12. Sakai, H.
13. Lingua, A.
14. Salman, P.
15. Souquet, P.-J.
16. De Marchi, P.
17. Martin, C.
18. Pérol, M.
19. Scherpereel, A.
20. Lu, S.
21. John, T.
22. Carbone, D.P.
23. Meadows-Shropshire, S.
24. Agrawal, S.
25. Oukessou, A.
26. Yan, J.
27. Reck, M.
28. Mostrar todos los/as autores/as +